[HTML][HTML] Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study
Background The benefit of apixaban to reduce stroke risk in morbidly obese patients with
nonvalvular atrial fibrillation (AF) is still undetermined. The International Society of …
nonvalvular atrial fibrillation (AF) is still undetermined. The International Society of …
[HTML][HTML] Comparative effectiveness and safety of direct oral anticoagulants vs warfarin among obese patients with atrial fibrillation
Background Obese patients are underrepresented in clinical trials assessing the
comparative effectiveness and safety of use of direct oral anticoagulants vs use in atrial …
comparative effectiveness and safety of use of direct oral anticoagulants vs use in atrial …